AUS
NZ
UK
CA
USA
IND
Healthcare
Kalkine: Noxopharm's Sofra™ Platform Gains Momentum with BioRay Study in ASX300 Biotech Space
June 11, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights,Noxopharm’s Sofra™ tech validated through BioRay testing,Promising inflammation-fighting results from oligonucleotide platform,Collaboration boosts Sofra’s potential as versatile ASX300 biotech innovation,Noxopharm Limited (ASX:NOX), a cli...
Kalkine: PME Shares Surge in ASX200: Exploring Growth, Tech & Ethical Edge in Healthcare
June 11, 2025 03:20 PM AEST| By Team Kalkine MediaHighlights,PME shares have risen over 12% YTD amid healthcare sector momentum,Visage technology positions Pro Medicus as a global leader in radiology software,Ethical and growth-focused exposure within the ASX200 healthcare ecosystem,The healthcare s...
Kalkine: Cyclopharm Gets Technegas Patent Extension, Boosting ASX200 Growth Story
June 11, 2025 01:57 PM AEST| By Team Kalkine MediaHighlights,Cyclopharm,secures US patent extension for,Technegas,to 2031,Strengthens exclusivity in world’s largest healthcare market,Bolsters,commercialisation,pathway in lung imaging space,Cyclopharm (ASX:CYC) has achieved a critical milestone in it...
Kalkine: Prescient Therapeutics Leads ASX200 Biotech Push With Innovations in Cancer Therapy (ASX:PTX)
June 11, 2025 11:19 AM AEST| By Team Kalkine MediaHighlights,PTX-100 targets high-mortality cancers linked to RAS mutations.,Prescient’s,cell therapies aim to enhance CAR-T effectiveness.,Fast-track designations support regulatory progress.,Prescient Therapeutics (ASX:PTX), a clinical-stage biotechn...
Kalkine: ASX 200 Eyes Innovation as Lyrebird Health Secures New Capital for AI Scribe Tool
June 10, 2025 03:22 PM AEST| By Team Kalkine MediaHighlights,Lyrebird Health completes funding round to strengthen AI-based clinical documentation platform,Backing from Five V Capital and Octopus Ventures supports global scale-up and regulatory compliance,Integration efforts continue with electronic...
Kalkine: Botanix (ASX:BOT) Strengthens Commercial Push with A$48M Facility Backing in ASX200 Spotlight
June 10, 2025 02:40 PM AEST| By Team Kalkine MediaHighlights,Botanix secures A$48M debt facility to fuel commercial rollout,Capital directed toward Sofdra™ launch and platform growth,Strategic financial moves bolster Botanix’s ASX200 presence,Botanix Pharmaceuticals Ltd (ASX:BOT), a clinical-stage p...
Kalkine: ASX 200 Watch: INOVIQ (ASX:IIQ) Updates on Cash Position Amid Sector Pressures
June 10, 2025 02:26 PM AEST| By Team Kalkine MediaHighlights,INOVIQ (ASX:IIQ) operates within the biotech sector, focusing on diagnostics and clinical development technologies,Company outlines updated cash position and reduced outflows over the past financial year,Sector sentiment influenced by broa...
Kalkine: EZZ Life Science Secures $21M South-East Asia Deal, Boosting ASX200 Exposure
June 10, 2025 02:21 PM AEST| By Team Kalkine MediaHighlights,EZZ inks $21 million South-East Asia deal,ROFA to distribute across Thailand, Vietnam, Singapore,US manufacturing to strengthen global presence,EZZ Life Science Holdings (ASX:EZZ) has taken a significant leap forward in its international e...
Kalkine: Monash IVF Faces Second Embryo Error in 2025, Stirring ASX200 Concerns
June 10, 2025 01:05 PM AEST| By Team Kalkine MediaHighlights,Monash IVF (MVF) reported a second embryo transfer error this year.,The company is introducing stricter verification and oversight.,MVF,remains,part of broader conversations in the ASX200 healthcare sector.,Shares of Monash IVF Group Ltd (...
Kalkine: Leadership Reshuffle at Anteris (ASX:AVR) Highlights Strategic Growth Amid ASX200 Momentum
June 10, 2025 12:09 PM AEST| By Team Kalkine MediaHighlights,Anteris,adds two independent directors to its board.,Governance reshuffle supports,pivotal,clinical phase.,Strong alignment with shareholder interests through equity-linked compensation.,Anteris Technologies (ASX:AVR), a developer of trans...
Kalkine: Future Fund Legal Chief Joins CSL Board Amid ASX200 Leadership Moves
June 10, 2025 10:38 AM AEST| By Team Kalkine MediaHighlights,Cameron Price to join CSL board as non-executive director,Transition follows over a decade of strategic leadership at Future Fund,CSL bolsters governance amid dynamic ASX200 market shifts,CSL Limited (ASX:CSL), one of the leading biotech g...
Kalkine: Leadership Change at Integral Diagnostics (ASX:IDX) as CEO Sets Retirement Timeline | ASX200 Update
June 06, 2025 05:07 PM AEST| By Team Kalkine MediaHighlights,Integral Diagnostics (IDX) CEO to retire by FY26-end,Leadership transition aligned with recent Capitol Health merger,New CEO search underway amid ASX200 index presence,Integral Diagnostics (ASX:IDX), a key player in the medical imaging spa...
Kalkine: Imugene Advances Cancer Pipeline with New Trial Milestones and CMO Leadership
June 06, 2025 01:43 PM AEST| By Team Kalkine MediaHighlights,Imugene Ltd (ASX:IMU, OTC:IUGNF) initiates Phase 2 trials for PD1-Vaxx in Australia,New CMO Dr John Byon focuses on durable responses in advanced therapies,Expansion into rare blood cancers and strategic development for onCARlytics continu...
Kalkine: Imugene’s Oncology Pipeline Progresses with Key Trials and ASX200 Outlook (ASX:IMU)
June 06, 2025 01:31 PM AEST| By Team Kalkine MediaHighlights,Dr John Byon appointed as chief medical office,Azer-cel shows durable responses post CAR-T failure,First site activated in PD1-Vaxx Phase 2 colorectal cancer trial,Imugene Ltd (ASX:IMU) continues to make strides in oncology innovation, rec...
Kalkine: EBR Systems Shares Surge on First US Implants, Gains Spotlight in ASX200 Landscape
June 06, 2025 11:32 AM AEST| By Team Kalkine MediaHighlights,EBR Systems performs first US commercial implants,Shares spike over 7% on the news,Positioned for upcoming limited market release,EBR Systems (ASX:EBR) made headlines after announcing a key milestone — the first commercial implantations of...
Kalkine: ASX 200 Faces Legal Uncertainty as Mayne Pharma Proceeds with Cosette Deal Vote
June 05, 2025 03:57 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma Group Ltd (ASX:MYX) to continue with shareholder vote on Cosette Pharma's acquisition,Cosette declares deal termination citing material change; Mayne challenges the claim,Supreme Court defers approval hearing pending outcome o...
Kalkine : ASX 200 Pharma Stock CU6 Surges on Positive Phase II Trial Update
June 05, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals shares rise sharply after a key clinical trial update,64Cu-SARTATE shows enhanced detection of NET lesions over current standard,Plans underway to progress into a registrational study with FDA guidance,Clarity Pharm...
Kalkine: ASX 200 Lifts as Clarity Pharma Reports Diagnostic Trial Milestone
June 05, 2025 03:43 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (ASX:CU6) announces positive phase two results for Cu-SARTATE in NET patients,Company plans to advance discussions with the US FDA for phase three diagnostic study,ASX 200 strengthens on healthcare gains and upbeat...
Kalkine: ASX 200 Healthcare Tech Sector Sees Lift as Ramsay CEO Joins EMVision Board
June 05, 2025 03:17 PM AEST| By Team Kalkine MediaHighlights,EMVision Medical Devices (ASX:EMV) welcomes Ramsay Health Care CEO Carmel Monaghan to its board,Monaghan brings decades of healthcare leadership experience to EMV as a non-executive director,Market movement observed following board appoint...
Kalkine: ASX 200 Healthcare: What’s Driving Movement in Cochlear Ltd (ASX:COH) Shares?
June 05, 2025 03:03 PM AEST| By Team Kalkine MediaHighlights,Cochlear Ltd (ASX:COH) shares have shown a decline since the start of the year amid broader healthcare sector trends,The healthcare sector continues to be influenced by essential service demand and consistent revenue models,Valuation metri...
Advertise your brand on Kalkine Media